Anti-MAP6D1 antibodies are used in the immunodetection of the protein MAP6 domain containing 1. In humans, the canonical protein has a reported length of 199 amino acid residues and a mass of 21 kDa. Its subcellular localization is in the Golgi and cytoplasm. It is notably expressed in the hippocampus, cerebral cortex, and caudate. A member of the STOP protein family, MAP6D1 is believed to have microtubule-stabilizing activity. Post-translational modifications have been described, including palmitoylation. Synonyms for this target antigen include 21 kDa STOP-like protein, STOP-Like protein 21 kD, and MAP6 domain-containing protein 1. MAP6D1 gene orthologs have been reported in the mouse, rat, bovine, zebrafish, chimpanzee and chicken species. These MAP6D1 antibodies are widely used in Western Blot experiments, among other applications.